Longeveron Inc. Featured in Syndicated Broadcast Highlighting Top-Line Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ for the Treatment of Mild Alzheimer's

We apologize for any inconvenience, but the press release has been removed from the website. This action was taken due to either receiving a complaint or at the request of the distribution agency. If you suspect there may have been an error, kindly reach out to our administrator for further assistance. Thank you for your understanding.

Market Details

Copyright © 2024 | All rights reserved